It outperformed Orexigen's Mysimba/Contrave weight loss drug, where around a quarter of patients in a phase 3 trial achieved the target. Semaglutide came out top of the analysis, with 63% of ...

When it comes to achieving healthy body weight, some men might look to what’s average and use that as their goal. For ...

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

State Senate holds a hearing on a controversial proposal to restrict diet pills and supplements for those under 18.

Lilly's retatrutide shows remarkable weight loss in trials but raises concerns with side effects possibly linked to the drug like nausea and kidney stones. Read more here.

Millions of Americans rely on GLP-1 drugs to improve their health, but bad actors are peddling dangerous fakes.” ...

Several local companies are developing technologies that they hope could replace a painful poke with something that feels more like having Velcro against your skin for a few minutes.

Health experts say popular weight-loss drugs like Ozempic and Wegovy are safe, but the FDA warns counterfeits are becoming more widespread.

The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...